Title: 3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists.
Journal: Bioorganic & medicinal chemistry letters 20090301
6595-67-1
81074-83-1
6504-55-8
5443-37-8 | Ethyl 4-(prop-2-en-1-yloxy)benzoate | AA00DUYJ | MFCD06204352
45434-73-9 | 3,4-Furandiamine, tetrahydro-, (3s,4s)- | AA00DW7S | MFCD18833628
473703-95-6 | 5-ISOPROPYL-4-METHOXY-2-METHYL-PHENYLAMINEHYDROCHLORIDE | AA00DZ32 | MFCD02173763
5004-94-4 | 4-Phenyl-4-piperidinol HCl | AA00E0GO | MFCD21605333
51925-57-6 | Methyl 2,4-dioxopyrrolidine-3-carboxylate | AA00E249 | MFCD21602602
55151-96-7 | (5-Methyl-1,2,4-oxadiazol-3-yl)acetic acid | AA00E4W3 | MFCD11584225
475152-16-0 | 1H-Spiro[furo[3,4-c]pyridine-3,4'-piperidin]-1-one hydrochloride | AA00E6R2 | MFCD13194944
64396-27-6 | DIFUCOSYLLACTO-N-HEXAOSE (A) | AA00E8IY | MFCD00467026
60388-38-7 | 2-Amino-5-trifluoromethylbenzothiazole | AA00E8PF | MFCD05861632
616239-57-7 | 4-METHYL-2-(TRIBUTYLSTANNYL)OXAZOLE | AA00E8WH | MFCD07787365